Study Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia

  • days left to enroll
  • participants needed
  • sponsor
    University Hospital, Tours
Updated on 1 March 2021
antibiotic therapy
mechanical ventilation


The objective of the study is to prove that after the third day of invasive mechanical ventilation a three-day course of inhaled amikacin reduces the incidence of subsequent VAP.

Parallel two group double blind randomized controlled clinical trial. Individual randomization, performed on day 4 of invasive mechanical ventilation, will be stratified on centre in order to account for variations in VAP prevention bundle implementation and use of systemic antibiotics the day of randomization. Patients will be treated three consecutive days with inhaled amikacin or placebo. Patients will be followed up daily in the intensive care unit for the occurrence of VAP according to international guidelines until day 28.

Condition Ventilator associated pneumonia
Treatment inhaled placebo, Inhaled amikacin
Clinical Study IdentifierNCT03149640
SponsorUniversity Hospital, Tours
Last Modified on1 March 2021


Yes No Not Sure

Inclusion Criteria

as deemed necessary by the clinician in charge
Stage 2 or 3 KDIGO classification acute kidney injury the day of inclusion excepted in patients undergoing renal replacement therapy
Chronic kidney failure : baseline glomerular filtration lower than 30 mL/min
Patient scheduled for extubation within the next 24h
Patient ventilated through an endotracheal tube for more than four consecutive days before inclusion (96h)
Patient ventilated through a tracheostomy
Patients allergic to aminoglycosides
Myasthenia gravis
Known pregnant women at the time of inclusion and lactating patients
Known guardianship or trusteeship at the time of inclusion
Patients previously included in this study

Exclusion Criteria

Suspicion or confirmed VAP the day of inclusion
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note